Toby Hirsch
Business Solutions Expert at Clearshift- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Clearshift
-
Israel
-
Financial Services
-
1 - 100 Employee
-
Business Solutions Expert
-
Nov 2020 - Present
Launching Clearshift's unique business model in the US. We are an Israeli fintech with a 10+ year track record of saving our customers millions of dollars in hidden fees on their international wire transfers. Unlike our competition, Clearshift is 100% transparent and honest on our pricing. Our customers always get the same ultra-low mark-up on each and every transaction. We never play games with our fees. Launching Clearshift's unique business model in the US. We are an Israeli fintech with a 10+ year track record of saving our customers millions of dollars in hidden fees on their international wire transfers. Unlike our competition, Clearshift is 100% transparent and honest on our pricing. Our customers always get the same ultra-low mark-up on each and every transaction. We never play games with our fees.
-
-
-
NATAN Worldwide Disaster Relief
-
Israel
-
Non-profit Organization Management
-
1 - 100 Employee
-
Volunteer
-
Jan 2023 - Present
-
-
-
Roche
-
Switzerland
-
Biotechnology Research
-
700 & Above Employee
-
Product Manager
-
2002 - 2006
Integral member of multidisciplinary Life Cycle Team working together to launch high profile, first in class antiretroviral drug for HIV/AIDS. Conducted market research with physicians, nurses and patients to develop an array of educational materials for providers and patients to aid patient compliance for complicated administration of drug. Collected data from patients and providers to provide updated “tips and tricks” for successful administration. Worked with nurses and end users of product to provide feedback to packaging and logistics departments to develop patient friendly kit for 30 day supply of drug taken BID. Coordinated press event at manufacturing plant in Boulder, Colorado to illustrate the complexities of production. Key strategy in managing messaging regarding pricing and limited supply at launch. Worked with plant scientists and engineers to stay on message and present a simplified version of production process for the lay press with understandable and impactful soundbites. Managed roll-out of limited supply of product at launch to subsidiaries in US, Canada, Europe, Australia, Latin America based on demand forecasts. Led emergency task force to identify suitable replacement of retractable safety syringes included in the patient kit. Developed communication plan to providers and consumers. Evaluated with clinical team feasibility of alternate modes of delivery of drug to facilitate acquisition of new and retention of existing patients. Wrote business plan for roll out of needle free injection technology. Show less
-
-
-
Schering Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Global Marketing Associate Product Manager
-
2000 - 2002
Responsible for all Remicade sales outside the United States. Provided strategic direction to international subsidiaries with strong marketing messaging platforms. Conducted market research and developed marketing materials for subsidiaries to use locally to ensure consistent promotion of Remicade around the world.Met with rheumatologists and gastroenterologist in international markets to understand their views and concerns regarding Remicade and used this information to overcome marketing challenges.As part of key strategy for success, organized Pan-European Quality of Life survey involving nearly 6,000 patients with Rheumatoid Arthritis to document the patient perspective. Recruited top 10 physician opinion leaders from major markets to serve on an Executive and a Steering Committee. Co-wrote the protocol and co-developed the Case Report Form with input from the committees. Directed the subsidiaries in formulating plans to execute the survey.Planned satellite symposium at the 2001 European Union League Against Rheumatism to present pivotal Phase III data for Remicade. Worked with three top opinion leaders in drafting presentations which covered clinical data and aligned messaging with overall marketing strategy. Evaluated marketing potential for current and future indications. Show less
-
-
Finance Management Associate
-
1998 - 2000
Completed 6 month rotations throughout the corporation including:• Schering Labs, Target Sales Rep for allergy franchise in lower Manhattan.• Global Strategic Development, Business Analyst evaluating licensing opportunities for drug compounds in various stages of development.• Diabetes Business Unit, Marketing Finance Manager responsible for reporting on all financial and budgetary issues.• Integrated Therapeutics Group, Outcomes Financial Analyst reviewing performance data on asthma health management programs for insurance companies to identify cost savings. Used data to negotiate contracts. Show less
-
-
-
Federal Reserve Bank of New York
-
United States
-
Financial Services
-
700 & Above Employee
-
Bank Examiner
-
1993 - 1998
Conducted over 25 bank inspections in the tri-state region. Managed teams reviewing and rating various aspects of bank operations, including credit risk management, asset liability management, internal audit and financial and strategic management.Sponsored to attend two year MBA program at Columbia Business School.
-
-
Banking Applications Analyst
-
1991 - 1993
Analyzed the financial impact, competitive effects and legal issues arising from bank mergers, acquisitions, and investment proposals requiring Federal Reserve approval. Wrote opinions and recommendations for the Board of Governors.
-
-
Education
-
Columbia University in the City of New York
Master of Business Administration - MBA, Marketing and Finance -
Yeshiva University
Bachelor of Arts - BA, Economics